Annual Operating Expenses
$139.69 M
-$2.53 M-1.78%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual total operating expenses is $139.69 million, with the most recent change of -$2.53 million (-1.78%) on December 31, 2023.
- During the last 3 years, PBYI annual operating expenses has fallen by -$76.45 million (-35.37%).
- PBYI annual operating expenses is now -55.58% below its all-time high of $314.50 million, reached on December 31, 2017.
Performance
PBYI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$29.37 M
-$9.24 M-23.93%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly total operating expenses is $29.37 million, with the most recent change of -$9.24 million (-23.93%) on September 30, 2024.
- Over the past year, PBYI quarterly operating expenses has dropped by -$4.26 million (-12.66%).
- PBYI quarterly operating expenses is now -64.84% below its all-time high of $83.53 million, reached on March 31, 2018.
Performance
PBYI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PBYI Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.8% | -12.7% |
| 3 y3 years | -35.4% | -9.8% |
| 5 y5 years | -55.1% | -9.8% |
PBYI Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.8% | at low | -24.4% | at low |
| 5 y | 5-year | -49.1% | at low | -52.2% | at low |
| alltime | all time | -55.6% | >+9999.0% | -64.8% | >+9999.0% |
Puma Biotechnology Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $29.37 M(-23.9%) |
| Jun 2024 | - | $38.60 M(+9.2%) |
| Mar 2024 | - | $35.34 M(+6.9%) |
| Dec 2023 | $139.69 M(-1.8%) | $33.06 M(-1.7%) |
| Sep 2023 | - | $33.62 M(-11.1%) |
| Jun 2023 | - | $37.82 M(+7.5%) |
| Mar 2023 | - | $35.19 M(-9.4%) |
| Dec 2022 | $142.22 M(-24.4%) | $38.82 M(+10.2%) |
| Sep 2022 | - | $35.21 M(+8.2%) |
| Jun 2022 | - | $32.54 M(-8.7%) |
| Mar 2022 | - | $35.64 M(-2.7%) |
| Dec 2021 | $188.16 M(-12.9%) | $36.63 M(-18.5%) |
| Sep 2021 | - | $44.92 M(-22.6%) |
| Jun 2021 | - | $58.05 M(+19.8%) |
| Mar 2021 | - | $48.47 M(-8.1%) |
| Dec 2020 | $216.14 M(-21.3%) | $52.77 M(-0.3%) |
| Sep 2020 | - | $52.94 M(-2.0%) |
| Jun 2020 | - | $54.04 M(-4.2%) |
| Mar 2020 | - | $56.39 M(-8.2%) |
| Dec 2019 | $274.49 M(-11.7%) | $61.45 M(+0.0%) |
| Sep 2019 | - | $61.43 M(-12.7%) |
| Jun 2019 | - | $70.38 M(-13.4%) |
| Mar 2019 | - | $81.23 M(+2.5%) |
| Dec 2018 | $311.02 M(-1.1%) | $79.26 M(+22.2%) |
| Sep 2018 | - | $64.86 M(-22.2%) |
| Jun 2018 | - | $83.38 M(-0.2%) |
| Mar 2018 | - | $83.53 M(+3.0%) |
| Dec 2017 | $314.50 M(+13.7%) | $81.13 M(-1.1%) |
| Sep 2017 | - | $81.99 M(+4.9%) |
| Jun 2017 | - | $78.18 M(+6.8%) |
| Mar 2017 | - | $73.20 M(+0.5%) |
| Dec 2016 | $276.60 M | $72.87 M(+10.4%) |
| Sep 2016 | - | $66.00 M(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $66.48 M(-6.7%) |
| Mar 2016 | - | $71.25 M(+14.8%) |
| Dec 2015 | $240.28 M(+68.9%) | $62.03 M(+2.1%) |
| Sep 2015 | - | $60.73 M(-6.4%) |
| Jun 2015 | - | $64.91 M(+23.4%) |
| Mar 2015 | - | $52.60 M(+10.5%) |
| Dec 2014 | $142.28 M(+159.5%) | $47.59 M(+32.4%) |
| Sep 2014 | - | $35.96 M(-7.6%) |
| Jun 2014 | - | $38.91 M(+96.3%) |
| Mar 2014 | - | $19.82 M(+24.0%) |
| Dec 2013 | $54.83 M(-26.3%) | $15.99 M(+11.6%) |
| Sep 2013 | - | $14.33 M(+12.8%) |
| Jun 2013 | - | $12.71 M(+7.6%) |
| Mar 2013 | - | $11.81 M(-46.2%) |
| Dec 2012 | $74.45 M(+633.0%) | $21.95 M(-15.2%) |
| Sep 2012 | - | $25.87 M(+75.1%) |
| Jun 2012 | - | $14.78 M(+24.7%) |
| Mar 2012 | - | $11.85 M(+21.1%) |
| Dec 2011 | $10.16 M(>+9900.0%) | $9.78 M(+2830.5%) |
| Sep 2011 | - | $333.90 K(+873.5%) |
| Jun 2011 | - | $34.30 K(+779.5%) |
| Mar 2011 | - | $3900.00(-218.2%) |
| Dec 2010 | $7000.00(-58.3%) | -$3300.00(-203.1%) |
| Sep 2010 | - | $3200.00(+33.3%) |
| Jun 2010 | - | $2400.00(-48.9%) |
| Mar 2010 | - | $4700.00(+42.4%) |
| Dec 2009 | $16.80 K(+19.1%) | $3300.00(0.0%) |
| Sep 2009 | - | $3300.00(-21.4%) |
| Jun 2009 | - | $4200.00(-30.0%) |
| Mar 2009 | - | $6000.00(+172.7%) |
| Dec 2008 | $14.10 K | $2200.00(-45.0%) |
| Sep 2008 | - | $4000.00(+17.6%) |
| Jun 2008 | - | $3400.00(-24.4%) |
| Mar 2008 | - | $4500.00 |
FAQ
- What is Puma Biotechnology annual total operating expenses?
- What is the all time high annual operating expenses for Puma Biotechnology?
- What is Puma Biotechnology annual operating expenses year-on-year change?
- What is Puma Biotechnology quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Puma Biotechnology?
- What is Puma Biotechnology quarterly operating expenses year-on-year change?
What is Puma Biotechnology annual total operating expenses?
The current annual operating expenses of PBYI is $139.69 M
What is the all time high annual operating expenses for Puma Biotechnology?
Puma Biotechnology all-time high annual total operating expenses is $314.50 M
What is Puma Biotechnology annual operating expenses year-on-year change?
Over the past year, PBYI annual total operating expenses has changed by -$2.53 M (-1.78%)
What is Puma Biotechnology quarterly total operating expenses?
The current quarterly operating expenses of PBYI is $29.37 M
What is the all time high quarterly operating expenses for Puma Biotechnology?
Puma Biotechnology all-time high quarterly total operating expenses is $83.53 M
What is Puma Biotechnology quarterly operating expenses year-on-year change?
Over the past year, PBYI quarterly total operating expenses has changed by -$4.26 M (-12.66%)